Ein Mann liest Wirtschaftsnachrichten (Symbolbild).
Montag, 05.12.2022 15:24 von | Aufrufe: 101

SHAREHOLDER ALERT: Weiss Law Reminds APEN, ABMD, BNFT, and FRSH Shareholders About Its Ongoing Investigations

Ein Mann liest Wirtschaftsnachrichten (Symbolbild). pixabay.com

PR Newswire

NEW YORK, Dec. 5, 2022 /PRNewswire/ -- 

If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact:

Joshua Rubin, Esq.
Weiss Law
305 Broadway, 7th Floor
New York, NY 10007
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com

Apollo Endosurgery, Inc. (NASDAQ: APEN)

Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Apollo Endosurgery, Inc. (NASDAQ: APEN), in connection with the proposed acquisition of APEN by Boston Scientific Corporation. Under the terms of the merger agreement, APEN shareholders will receive $10.00 in cash for each share of APEN common stock owned. If you own APEN shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslaw.co/news-and-cases/apen

Abiomed, Inc. (NASDAQ: ABMD)


ARIVA.DE Börsen-Geflüster

Kurse

-  
0,00%
Abiomed Chart
Apollo Endosurgery Chart
-  
0,00%
Benefitfocus Chart
17,20
0,00%
Freshworks Inc. Realtime-Chart

Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Abiomed, Inc. (NASDAQ: ABMD), in connection with its proposed tender offer by Johnson & Johnson. Under the tender offer, ABMD shareholders will receive $380.00 in cash, reflecting an enterprise value of approximately $16.6 billion, and a non-tradeable contingent value right (CVR) entitling the holder to receive up to $35.00 for each share of ABMD common stock owned. If you own ABMD shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslaw.co/news-and-cases/abmd

Benefitfocus, Inc. (NASDAQ: BNFT)

Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Benefitfocus, Inc. (NASDAQ: BNFT), in connection with the proposed acquisition of BNFT by Voya Financial, Inc. Under the terms of the merger agreement, BNFT shareholders will receive $10.50 in cash for each share of BNFT common stock owned. If you own BNFT shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslaw.co/news-and-cases/bnft 

Freshworks Inc. (NASDAQ: FRSH)

Weiss Law, a national shareholder rights law firm, is investigating possible breaches of fiduciary duty and violations of the federal securities laws by, among others, the Board of Directors and senior officers of Freshworks Inc. (NASDAQ: FRSH) concerning misleading statements and omissions connected with the company's initial public offering ("IPO"). If you own FRSH shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslaw.co/news-and-cases/frsh

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert-weiss-law-reminds-apen-abmd-bnft-and-frsh-shareholders-about-its-ongoing-investigations-301694944.html

SOURCE Weiss Law

Werbung

Mehr Nachrichten zur Abiomed Aktie kostenlos abonnieren

E-Mail-Adresse
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.